BR112012007815A2 - quantificação multiplex de proteínas recombinantes em uma mistura por peptídeos de assinatura e espectrometria de massa. - Google Patents
quantificação multiplex de proteínas recombinantes em uma mistura por peptídeos de assinatura e espectrometria de massa.Info
- Publication number
- BR112012007815A2 BR112012007815A2 BR112012007815A BR112012007815A BR112012007815A2 BR 112012007815 A2 BR112012007815 A2 BR 112012007815A2 BR 112012007815 A BR112012007815 A BR 112012007815A BR 112012007815 A BR112012007815 A BR 112012007815A BR 112012007815 A2 BR112012007815 A2 BR 112012007815A2
- Authority
- BR
- Brazil
- Prior art keywords
- recombinant proteins
- mixture
- mass spectrometry
- signature peptides
- multiplex
- Prior art date
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title abstract 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title abstract 3
- 238000004949 mass spectrometry Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 238000011002 quantification Methods 0.000 title 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 239000012228 culture supernatant Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200901112 | 2009-10-09 | ||
| US25623209P | 2009-10-29 | 2009-10-29 | |
| PCT/DK2010/050258 WO2011042027A2 (en) | 2009-10-09 | 2010-10-07 | Multiplex quantitation of individual recombinant proteins in a mixture by signature peptides and mass spectrometry |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012007815A2 true BR112012007815A2 (pt) | 2018-03-20 |
Family
ID=42166454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012007815A BR112012007815A2 (pt) | 2009-10-09 | 2010-10-07 | quantificação multiplex de proteínas recombinantes em uma mistura por peptídeos de assinatura e espectrometria de massa. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120264155A1 (https=) |
| EP (1) | EP2486411A2 (https=) |
| JP (1) | JP2013507603A (https=) |
| KR (1) | KR20120100982A (https=) |
| CN (1) | CN102687020A (https=) |
| AU (1) | AU2010305150A1 (https=) |
| BR (1) | BR112012007815A2 (https=) |
| CA (1) | CA2776508A1 (https=) |
| IL (1) | IL218821A0 (https=) |
| IN (1) | IN2012DN03911A (https=) |
| MX (1) | MX2012003538A (https=) |
| RU (1) | RU2012118620A (https=) |
| WO (1) | WO2011042027A2 (https=) |
| ZA (1) | ZA201202431B (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2241875A1 (en) * | 2009-04-14 | 2010-10-20 | Koninklijke Philips Electronics N.V. | Up-concentration of organic microobjects for microscopic imaging. |
| KR101992502B1 (ko) * | 2011-05-12 | 2019-06-24 | 제넨테크, 인크. | 프레임워크 시그너처 펩티드를 사용하여 동물 샘플에서 치료 항체를 검출하기 위한 다중 반응 모니터링 lc-ms/ms 방법 |
| WO2013019714A1 (en) | 2011-07-29 | 2013-02-07 | The Trustees Of Columbia University In The City Of New York | Mems affinity sensor for continuous monitoring of analytes |
| WO2016022696A1 (en) | 2014-08-05 | 2016-02-11 | The Trustees Of Columbia University In The City Of New York | Method of isolating aptamers for minimal residual disease detection |
| WO2016145390A1 (en) | 2015-03-12 | 2016-09-15 | Mars, Incorporated | Ultra high resolution mass spectrometry and methods of using the same |
| US10794916B2 (en) | 2015-05-06 | 2020-10-06 | Momenta Pharmaceuticals, Inc. | Methods of glycoprotein analysis |
| CN105242050A (zh) * | 2015-09-16 | 2016-01-13 | 同济大学 | 一种不同生理或病理条件下整体蛋白质的定量分析方法 |
| CN105218671A (zh) * | 2015-09-29 | 2016-01-06 | 李艳华 | 一种传染病病原体全人源化抗体的制备方法 |
| GB201603291D0 (en) * | 2016-02-25 | 2016-04-13 | Binding Site Group The Ltd | Antibodies |
| US20170315132A1 (en) * | 2016-03-25 | 2017-11-02 | Genentech, Inc. | Multiplexed total antibody and antibody-conjugated drug quantification assay |
| EP3465221B1 (en) | 2016-05-27 | 2020-07-22 | H. Hoffnabb-La Roche Ag | Bioanalytical method for the characterization of site-specific antibody-drug conjugates |
| CN107525934A (zh) * | 2016-06-21 | 2017-12-29 | 张效龙 | 一种测定血液中抗体氨基酸序列的方法 |
| WO2018035350A1 (en) * | 2016-08-17 | 2018-02-22 | Momenta Pharmaceuticals, Inc. | Glycan oxonium ion profiling of glycosylated proteins |
| CN108072728A (zh) * | 2016-11-16 | 2018-05-25 | 中国科学院大连化学物理研究所 | 一种基于数据依赖性质谱扫描模式的谱图库建立方法及其应用 |
| CN108956789A (zh) * | 2017-05-17 | 2018-12-07 | 中国科学院大连化学物理研究所 | 一种血清中免疫球蛋白g糖肽的绝对定量分析方法 |
| SG11202000727SA (en) * | 2017-08-01 | 2020-02-27 | Amgen Inc | Systems and methods for real time preparation of a polypeptide sample for analysis with mass spectrometry |
| US10615016B2 (en) * | 2017-09-07 | 2020-04-07 | Thermo Fisher Scientific (Bremen) Gmbh | Determining isotope ratios using mass spectrometry |
| CN108169397B (zh) * | 2017-11-30 | 2019-11-15 | 中国农业科学院北京畜牧兽医研究所 | 一种相对定量分析肉鸡谷胱甘肽s转移酶gsta2的方法 |
| CN108226516B (zh) * | 2017-11-30 | 2020-05-19 | 中国农业科学院北京畜牧兽医研究所 | 一种相对定量分析肉鸡脂肪酸去饱和酶fads1的方法 |
| CN109900815B (zh) * | 2017-12-08 | 2021-06-29 | 中国科学院大连化学物理研究所 | 血清中IgG糖肽的绝对定量分析 |
| CN112135839A (zh) * | 2018-01-31 | 2020-12-25 | 瑞泽恩制药公司 | 作为治疗性单克隆抗体上的新酸性翻译后修饰的葡糖醛酸化 |
| JP7205077B2 (ja) * | 2018-05-10 | 2023-01-17 | 株式会社島津製作所 | 分析方法、処理装置、分析装置およびプログラム |
| CN110824096B (zh) * | 2018-08-13 | 2022-11-29 | 齐鲁制药有限公司 | 一种蛋白错配二硫键的分析方法 |
| CN110007019A (zh) * | 2019-03-29 | 2019-07-12 | 绿城农科检测技术有限公司 | 一种同时定量检测母乳中三种抗体含量的方法 |
| GB201910697D0 (en) * | 2019-07-26 | 2019-09-11 | Binding Site Group Ltd | Lonisation control |
| US20230089196A1 (en) | 2020-02-21 | 2023-03-23 | Genmab B.V. | Methods for the quantification of glycoproteins |
| CN111551739A (zh) * | 2020-04-27 | 2020-08-18 | 杭州璞湃科技有限公司 | 一种免疫球蛋白a和免疫球蛋白a1的检测方法及其试剂盒 |
| WO2021258114A1 (en) * | 2020-06-18 | 2021-12-23 | Northwestern University | Process for direct readout of immunoglobulins |
| JP7478040B2 (ja) * | 2020-06-25 | 2024-05-02 | シスメックス株式会社 | Ａβペプチドの測定方法及びその方法に用いられる試薬組成物 |
| CN111766323B (zh) * | 2020-07-10 | 2022-06-14 | 中国检验检疫科学研究院 | 一种用于检测骆驼奶中掺入牛奶的特征肽组合及方法 |
| CN113933409B (zh) * | 2021-09-14 | 2023-11-14 | 上海中科新生命生物科技有限公司 | 基于液相色谱-质谱检测血清中特瑞普利单抗的方法 |
| DE102022115561B4 (de) * | 2022-06-22 | 2024-06-13 | Bruker Daltonics GmbH & Co. KG | Massenspektrometrische Bestimmung der Zelltoxizität |
| CN118221778A (zh) * | 2024-04-25 | 2024-06-21 | 烟台大学 | 拟穴青蟹Scyreprocin蛋白的特征肽段及其在雌雄鉴别方面的应用 |
| CN120399082B (zh) * | 2025-07-04 | 2025-08-26 | 北京溯本源和生物科技有限公司 | 一种用于检测猫Cys-C蛋白的单克隆抗体组合及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003087834A2 (en) * | 2002-04-08 | 2003-10-23 | Affinium Pharmaceuticals, Inc. | High throughput analysis of recombinant proteins in multi-well plates |
| EP2186879B1 (en) | 2002-10-03 | 2016-11-23 | Norman Leigh Anderson | High sensitivity quantitation of peptides by mass spectrometry |
| WO2005124341A2 (en) * | 2004-06-09 | 2005-12-29 | Anderson Forschung Group Llc | Stable isotope labeled polypeptide standards for protein quantitation |
| ES2332524T3 (es) * | 2004-07-20 | 2010-02-08 | Symphogen A/S | Un procedimiento para la caracterizacion de una linea celular policlonal. |
| KR20070038556A (ko) | 2004-07-20 | 2007-04-10 | 심포젠 에이/에스 | 항-ｒｈｅｓｕｓ ｄ 재조합 폴리클로날 항체 및 이의 제조방법 |
| US20090298196A1 (en) * | 2005-01-28 | 2009-12-03 | Uwabe Ken-Ichiro | Quantitative measurement method for recombinant protein |
| JP2006300758A (ja) * | 2005-04-21 | 2006-11-02 | Apro Life Science Institute Inc | 内部標準ペプチドを用いて生体由来試料に含まれる標的タンパク質を定量する方法 |
| EP2314619A1 (en) | 2005-12-05 | 2011-04-27 | Symphogen A/S | Anti-orthopoxvirus recombinant polyclonal antibody |
| JP2009528828A (ja) | 2006-03-06 | 2009-08-13 | シムフォゲン・アクティーゼルスカブ | 消化器多核体ウイルス感染症の治療のための組み換えポリクローナル抗体 |
| CN101675075B (zh) | 2007-03-01 | 2014-06-18 | 西福根有限公司 | 重组抗表皮生长因子受体抗体组合物 |
| WO2008106980A2 (en) | 2007-03-06 | 2008-09-12 | Symphogen A/S | Recombinant antibodies for treatment of respiratory syncytial virus infections |
| US20090000419A1 (en) * | 2007-06-29 | 2009-01-01 | Harley-Davidson Motor Company Group, Inc. | Handlebar assembly with axial locking feature |
-
2010
- 2010-10-07 RU RU2012118620/15A patent/RU2012118620A/ru unknown
- 2010-10-07 CN CN2010800562278A patent/CN102687020A/zh active Pending
- 2010-10-07 EP EP10774121A patent/EP2486411A2/en not_active Withdrawn
- 2010-10-07 AU AU2010305150A patent/AU2010305150A1/en not_active Abandoned
- 2010-10-07 JP JP2012532458A patent/JP2013507603A/ja active Pending
- 2010-10-07 CA CA2776508A patent/CA2776508A1/en not_active Abandoned
- 2010-10-07 BR BR112012007815A patent/BR112012007815A2/pt not_active IP Right Cessation
- 2010-10-07 US US13/501,051 patent/US20120264155A1/en not_active Abandoned
- 2010-10-07 IN IN3911DEN2012 patent/IN2012DN03911A/en unknown
- 2010-10-07 MX MX2012003538A patent/MX2012003538A/es not_active Application Discontinuation
- 2010-10-07 WO PCT/DK2010/050258 patent/WO2011042027A2/en not_active Ceased
- 2010-10-07 KR KR1020127011934A patent/KR20120100982A/ko not_active Withdrawn
-
2012
- 2012-03-25 IL IL218821A patent/IL218821A0/en unknown
- 2012-04-03 ZA ZA2012/02431A patent/ZA201202431B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010305150A1 (en) | 2012-04-05 |
| RU2012118620A (ru) | 2013-11-20 |
| IN2012DN03911A (https=) | 2015-09-04 |
| JP2013507603A (ja) | 2013-03-04 |
| IL218821A0 (en) | 2012-06-28 |
| CN102687020A (zh) | 2012-09-19 |
| EP2486411A2 (en) | 2012-08-15 |
| WO2011042027A2 (en) | 2011-04-14 |
| WO2011042027A3 (en) | 2011-09-22 |
| ZA201202431B (en) | 2012-12-27 |
| US20120264155A1 (en) | 2012-10-18 |
| KR20120100982A (ko) | 2012-09-12 |
| CA2776508A1 (en) | 2011-04-14 |
| MX2012003538A (es) | 2012-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012007815A2 (pt) | quantificação multiplex de proteínas recombinantes em uma mistura por peptídeos de assinatura e espectrometria de massa. | |
| BR112013031284A2 (pt) | composições, métodos, e kits para quantificar analitos alvo em uma amostra | |
| JO3615B1 (ar) | جسم مضاد كعامل نوعي تجاه الدايمر ألفا -4- بيتا-7-غير المتجانس | |
| WO2011149942A3 (en) | Compositions and methods for plasma peptide analysis | |
| BR112013029959A8 (pt) | Anticorpos anti-cgrp e anti-cgrpr e seu uso para prevenir ou inibir fotofobia ou aversão à luz, composição farmacêutica compreendendo os referidos anticorpos, bem como sequência de ácido nucleico e célula recombinante | |
| GB2468747B (en) | Method of protein sequencing using MALDI mass spectrometry | |
| MX346731B (es) | Producción de proteínas heteromultiméricas. | |
| ATE517192T1 (de) | Verfahren zur isolierung von zellen | |
| WO2014146139A3 (en) | Srm assay to indicate cancer therapy | |
| BR112013021562A2 (pt) | anticorpos para cd70 | |
| BRPI0818765A8 (pt) | Polipeptídeo, anticorpo ou seu fragmento de ligação de antígeno, polinucleotídeo, célula hospedeira, vetor, composição, uso e método para produzir polipeptídeo | |
| BR112014008694A2 (pt) | moléculas de ácido nucleico policistrônico recombinante | |
| BR112012026766A2 (pt) | métodos in vitro para gerar uma proteína heterodimérica, para a seleção de um anticorpo biespecífico e para inibir o crescimento, vetor de expressão, célula hospedeira, proteína heterodimérica, composição farmacêutica. | |
| CL2013002623A1 (es) | Moleculas de union biespecificas que comprende al menos un componente que se une a vegf y ang2 y al menos un componente de union de albumina sérica; molecula de acido nucleico que codifica la molecula de union biespecifica; célula hospedera que comprende la molecula de acido nucleico; composicion farmaceutica que comprende dicha molecula. | |
| MX2010008099A (es) | Anticuerpos y angiopoyetina-2 estabilizados y sus usos. | |
| MX2012004310A (es) | Metodo para caracterizar almenos un microorganismo por medio de espectrometria de masa. | |
| BR112012001171A2 (pt) | método de seleção. evolução e expressão de um articorpo ou fragmento de anticorpo, métodos de evolução e expressão de um anticorpo e de uma proteína, método de evolução e de fabricação de uma proteína, método de evolução para expressão intensificada e fabricação de uma proteína, método para identificar e produzir uma proteína,e, método de evolução de uma proteína. | |
| ZA201109222B (en) | Analysis and assay of glycated haemoglobins by capillary electrophoresis, buffer compositions, and kits for capillary electrophoresis | |
| BR112012004697A2 (pt) | purificação melhorada de proteína através de uma eluição da proteína a modificada. | |
| BR112013007871A2 (pt) | quantificação e caracterização de alérgenos | |
| WO2012135730A3 (en) | Method for verifying bioassay samples | |
| MX340683B (es) | Anticuerpos anti-vla-4. | |
| BR112012012911A2 (pt) | métodos para triar uma molécula capaz de ligação a cd4, para produzir uma composição terapêutica, para triar um anticorpo ou fragmento de anticorpo, in vitro para a ativação de células t regulatórias cd4+cd25+, para tratar um indivíduo, e para triar a presença de células regulatórias t cd4+cd25+ em uma amostra, composição terapêutica, anticorpo ou fragmento de anticorpo, peptídeo isolado, mimótopo de um peptídeo isolado, ácido nucleico, vetor, célula hospedeira ou hibridoma, usos de um anticorpo ou fragmento de anticorpo, do peptídeo isolado e de uma célula t regulatória cd4+cd25+, célula t regulatória cd4+cd25+, e, kit. | |
| NZ771197A (en) | Secretome profile-facilitated in vitro fertilization | |
| BR122020012978A8 (pt) | Método de quantificação de um produto específico em uma reação de amplificação por corte e extensão (near) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2465 DE 03-04-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |